肿瘤免疫治疗药物程序性死亡分子/程序性死亡配体抑制剂的不良反应挖掘及评价
陈爽, 郑淑芬, 张述耀, 钟诗龙
Adverse reactions of tumor immunotherapy drugs—PD-1/PD-L1 inhibitors
CHEN Shuang, ZHENG Shufen, ZHANG Shuyao, ZHONG Shilong
中国药物警戒 . 2022, (10): 1107 -1112 .  DOI: 10.19803/j.1672-8629.20210124